Chemoprophylaxis

Using chemoprophylaxis as a treatment against early signs of tuberculosis has proven to be effective. In familial adenomatous polyposis physicians observed polyps regression with NSAIDs for anti-inflammatory therapy. Chemoprophylaxis is also used to treat several different varieties of meningococcal infections for close contact exposure to Neisseria meningitidis. The World Health Organization recommends chemoprevention to prevent Malaria in the Sahel region of Sub-Saharan Africa through the use of the drugs sulfadoxine/pyrimethamine and amodiaquine. This technique is called Seasonal Malaria Chemoprevention (SMC). The charity evaluator GiveWell lists the Malaria Consortium's SMC program as one of its priority programs due to its high level of cost-effectiveness and ability to absorbe additional funding. == Cancer ==

Chemoprevention in cancer, was first proposed by Michael Sporn, seeks to identify ‘agents to reverse, suppress or prevent the carcinogenic process,’ from premalignancy to invasive and or metastatic cancer, by ‘using physiological mechanisms that do not kill healthy cells. Anand Reddi proposed a role for the antidiabetes drug metformin as a chemoprevention agent for skin cancer. ==See also==